Quantitation of peripheral blood cytomegalovirus DNA for monitoring recurrent cytomegalovirus retinitis in pediatric solid organ transplant recipients

Pediatric Transplantation

Volumn 4, Issue 2, 2000, Pages 100-106

  Aw, M M ^a   Murugasu, B ^a   Tan, A W ^a   Seah, C C ^a   Balakrishnan, V ^a   Yap, Hui Kim ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

CMV DNA; Retinitis; Solid organ transplantation

Indexed keywords

VIRUS DNA;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CYTOMEGALOVIRUS INFECTION; FEMALE; HEALTH CARE COST; HUMAN; MALE; ORGAN TRANSPLANTATION; POLYMERASE CHAIN REACTION; PRIMARY INFECTION; RECURRENT DISEASE; RETINITIS;

ADOLESCENT; ANTIVIRAL AGENTS; CHILD; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS RETINITIS; DNA, VIRAL; FEMALE; GANCICLOVIR; HUMANS; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MALE; POLYMERASE CHAIN REACTION; POSTOPERATIVE COMPLICATIONS; RECURRENCE;

EID: 0034070486     PISSN: 13973142     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3046.2000.00095.x     Document Type: Article

References (35)

1. STRATTA RJ, SHAEFFER MS, MARKIN RS, et al. Cytomegalovirus infection and disease after liver transplantation: an overview. Dig Dis Sci 1992: 37: 673-688.
2. SINGH N, DUMMER JS, KUSNE S, et al. Infections with cytomegalovirus and other herpesviruses in 121 liver transplant recipients: Transmission by donated organ and the effect of OKT3 antibodies. J Infect Dis 1988: 158: 124-131.
3. IRAGORRI S, PILLAY D, SCRINE M, TROMPETER RS, REES L, GRIFFITHS PD. Prospective cytomegalovirus surveillance in pediatric renal transplant patients. Pediatr Nephrol 1993: 7: 55-60.
4. MELLON A, SHEPARD RQ, FAOAGALI L, et al. Cytomegalovirus infection after liver transplantation in children. J Gastroenterol Hepatol 1993: 8: 540-544.
5. FALAGAS ME, SNYDMAN DR. Recurrent cytomegalovirus disease in solid-organ transplant recipients. Transplant Proc 1995: 27: 34-37.
6. JORDAN ML, HREBINKO RL, DUMMER JS, et al. Therapeutic use of ganciclovir for invasive cytomegalovirus infection in cadaveric renal allograft recipients. J Urol 1992: 148: 1388-1392.
7. MCCLUSKEY PJ, HALL AJ, LIGHTMAN S. Managing HIV. Part 5: HIV and eye disease. Med J Aust 1996: 164: 484-486.
8. QUINLAN MF, SALMON JF. Opthalmic complications in heart transplantation. J Heart Lung Transplant 1993: 12: 252-255.
9. WAPNER F, LEIB ML, DRUSIN R, et al. Ocular complications associated with cardiac transplantation. Trans Am Opthalmol Soc 1992: 90: 171-178.
10. FISHBURNE BC, MITRANI AA, DAVIS JL. Cytomegalovirus retinitis after cardiac transplantation. Am J Opthalmol 1998: 125: 104-106.
11. SIM SK, YAP HK, MURUGASU B, PRABHAKARAN K, HO CL. Infections in pediatric renal transplant recipients. Ann Acad Med Singapore 1997: 26: 290-293.
12. DREW WL. Diagnosis of cytomegalovirus infection. Rev Infect Dis 1988: 10 (Suppl. 3): 468-475.
13. TOYODA M, CARLOS JB, GALERA OA, et al. Correlation of cytomegalovirus DNA levels with response to antiviral therapy in cardiac and renal allograft recipients. Transplantation 1997: 63: 957-963.
14. MANEZ RST, GEORGE K, LINDEN P, et al. Diagnosis of cytomegalovirus infections by shell vial assay and conventional cell culture during antiviral prophylaxis. J Clin Microbiol 1994: 32: 2655-2659.
15. DESMET MD. Differential diagnosis of retinitis and choroiditis in patients with acquired immunodeficiency syndrome. Am J Med 1992: 92 (Suppl. 2A): S17-S21.
16. RATNAMOHAN VM, MATHYS JM, MCKENZIE A, CUNNINGHAM AL. HCMV-DNA is detected more frequently than infectious virus in blood leucocytes of immunocompromised patients: a direct comparison of culture-immunofluorescence and PCR for detection of HCMV in clinical specimens. J Med Virol 1992: 38: 252-259.
17. JIWA NM, VAN GEMERT GW, RAAP AK, et al. Rapid detection of human cytomegalovirus DNA in peripheral blood leukocytes of viremic transplant recipients by the polymerase chain reaction for cytomegalovirus. Transplantation 1989: 48: 72-76.
18. LUBIN MB, ELASHOFF JD, WANG SJ, ROTTER JI, TOYODA H. Precise gene dosage determination by polymerase chain reaction: theory, methodology, and statistical approach. Mol Cell Probes 1991: 5: 307-317.
19. EGBERT PR, POLLARD PB, GALLAGER JG, MERIGON TC. Cytomegalovirus retinitis in the immunosuppressed hosts. II. Ocular manifestations. Ann Intern Med 1980: 93: 664-670.
20. BOWEN EF, WILSON P, ATKINS M, et al. Natural history of untreated cytomegalovirus retinitis. Lancet 1995: 346: 1671-1673.
21. THE TH, VAN DER PLOEG M, VAN DEN BERG AP, et al. Direct detection of cytomegalovirus in peripheral blood leukocytes - a review of the antigenemia assay and polymerase chain reaction. Transplantation 1992: 54: 193-198.
22. MANEZ R, KUNSE S, RINALDO C, et al. Time to detection of cytomegalovirus (CMV) DNA in blood leukocytes is a predictor for the development of CMV disease in CMV-seronegative recipients of allografts from CMV-seropositive donors following liver transplantation. J Infect Dis 1996: 173: 1072-1076.
23. LO CY, HO KN, YUEN KY, et al. Diagnosing cytomegalovirus disease in CMV seropositive renal allograft recipients: a comparison between the detection of CMV DNAemia by polymerase chain reaction and antigenemia by CMV pp65 assay. Clin Transplant 1997: 11: 286-293.
24. BOLAND JD, DE GAST GC, HENE RJ, et al. Early detection of active cytomegalovirus infection after heart and kidney transplantation by testing for immediate early antigenemia and influence of cellular immunity on the occurrence of CMV infection. J Clin Microbiol 1990: 28: 2069-2075.
25. LOCATELLI F, PERCIVALLE E, COMOLI P, et al. Human cytomegalovirus infection in paediatric patients given allogenic bone marrow transplantation; role of early antiviral treatment for HCMV antigenemia on patients' outcome. Br J Haematol 1994: 88: 64-71.
26. GERNA G, BALDANTI F, SARASINI A, et al. Effect of foscarnet treatment on quantitation of human cytomegalovirus DNA in blood polymorphonuclear leukocytes and aqueous humor of AIDS patients with HCMV retinitis. Antimicrob Agents Chemother 1994: 38: 38-44.
27. GERNA G, BALDANTI F, SARASINI A, et al. Quantitative systemic and local evaluation of the antiviral effect of ganciclovir and foscarnet induction treatment on human cytomegalovirus gastrointestinal disease of patients with AIDS. Antiviral Res 1997: 34: 39-50.
28. GROSSI P, MINOLI L, PERCIVALLE E, IRISH W, VIGANO M, GERNA G. Clinical and virological monitoring of human cytomegalovirus infection in 294 heart transplant recipients. Transplantation 1995: 59: 847-851.
29. GERNA G, ZAVATTONI M, BALDANTI F, et al. Human cytomegalovirus leukoDNAemia correlates more closely with clinical symptoms than antigenemia and viremia in heart and heart-lung transplant recipients with primary HCMV infection. Transplantation 1998: 65: 1378-1385.
30. SCHMIDT CA, OETTLE H, PENG R, et al. Comparison of polymerase chain reaction from plasma and buffy-coat with antigen detection and occurrence of IgM for the detection cytomegalovirus infection after liver transplantation. Transplantation 1995: 59: 1133-1138.
31. PROSCH S, KIMEL V, DAWYDAWA I, KRUGER DH. Monitoring of patients for cytomegalovirus after organ transplantation by centrifugation culture and PCR. J Med Virol 1992: 38: 246-251.
32. PATEL R, SMITH TF, ESPY M, et al. A prospective comparison of molecular diagnostic techniques for the early detection of cytomegalovirus in liver transplant recipients. J Infect Dis 1995: 171: 1010-1014.
33. ZIPETO D, MORRIS S, HONG C, et al. Human cyto-megalovirus DNA in plasma reflects quantity of CMV DNA present in leukocytes. J Clin Microbiol 1995: 33:2607-2611.
34. MULTIMER D, MATYI-TOTH A, SHAW J, ELIAS E, O'DONNEL K, STALHANDSKE P. Patterns of viremia in liver transplant recipients with symptomatic cytomegalovirus infection. Transplantation 1997: 68: 68-73.
35. HANSEN KK, RICKSTEN A, HOFMANN B, NORRILD B, OLOFSSON S, MATHIESEN L. Detection of cytomegalovirus DNA in serum correlates with clinical cytomegalovirus retinitis in AIDS. J Infect Dis 1994: 170: 1271-1274.